Standard BioTools Signs New Agreement for Mass Cytometry Business Sale
Standard BioTools has entered into a new purchase agreement with Element Biosystems, a subsidiary of GMT Venture, for its Mass Cytometry business. This comes after Standard BioTools determined that GMT Venture's unsolicited acquisition proposal was superior to previous offers.